ImportRefusal LogoImportRefusal

Pablo Francisco Beltran Sanchez

⚠️ High Risk

FEI: 3010048354 • Quito, Pichincha • ECUADOR

FEI

FEI Number

3010048354

📍

Location

Quito, Pichincha

🇪🇨

Country

ECUADOR
🏢

Address

Eloy Alfaro Lt 4 & Panamericana Norte, , Quito, Pichincha, Ecuador

High Risk

FDA Import Risk Assessment

56.8
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

19
Total Refusals
9
Unique Violations
5/5/2025
Latest Refusal
12/22/2021
Earliest Refusal

Score Breakdown

Violation Severity
48.7×40%
Refusal Volume
48.2×30%
Recency
86.4×20%
Frequency
56.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7516×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

32411×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

48211×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

3288×

USUAL NAME

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(1) of the FD&C Act in that the label fails to bear the common or usual name of the food, if any there be.

3217×

LACKS N/C

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.

3207×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

4734×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

2182×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

4882×

HEALTH C

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.

Refusal History

DateProductViolationsDivision
5/5/2025
31NGT99NOVELTY TEAS, N.E.C.
320LACKS FIRM
321LACKS N/C
324NO ENGLISH
328USUAL NAME
482NUTRIT LBL
75UNAPPROVED
Division of Northeast Imports (DNEI)
5/5/2025
31NGT99NOVELTY TEAS, N.E.C.
320LACKS FIRM
321LACKS N/C
324NO ENGLISH
328USUAL NAME
482NUTRIT LBL
75UNAPPROVED
Division of Northeast Imports (DNEI)
5/5/2025
31NGT99NOVELTY TEAS, N.E.C.
320LACKS FIRM
321LACKS N/C
324NO ENGLISH
328USUAL NAME
482NUTRIT LBL
75UNAPPROVED
Division of Northeast Imports (DNEI)
5/5/2025
31NGT99NOVELTY TEAS, N.E.C.
320LACKS FIRM
321LACKS N/C
324NO ENGLISH
328USUAL NAME
482NUTRIT LBL
75UNAPPROVED
Division of Northeast Imports (DNEI)
5/5/2025
31NGT99NOVELTY TEAS, N.E.C.
320LACKS FIRM
321LACKS N/C
324NO ENGLISH
328USUAL NAME
482NUTRIT LBL
75UNAPPROVED
Division of Northeast Imports (DNEI)
3/13/2025
31NGT99NOVELTY TEAS, N.E.C.
320LACKS FIRM
321LACKS N/C
324NO ENGLISH
328USUAL NAME
482NUTRIT LBL
Division of Northeast Imports (DNEI)
3/13/2025
31NGT99NOVELTY TEAS, N.E.C.
320LACKS FIRM
321LACKS N/C
324NO ENGLISH
328USUAL NAME
482NUTRIT LBL
Division of Northeast Imports (DNEI)
8/14/2024
54EFY55PLANTAIN (E.G., WEED), (HERBAL & BOTANICAL TEAS)
324NO ENGLISH
473LABELING
482NUTRIT LBL
488HEALTH C
75UNAPPROVED
Division of Northeast Imports (DNEI)
8/14/2024
54EFY99HERBALS & BOTANICAL TEAS, N.E.C.
324NO ENGLISH
473LABELING
482NUTRIT LBL
75UNAPPROVED
Division of Northeast Imports (DNEI)
8/14/2024
54FFY99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
324NO ENGLISH
473LABELING
482NUTRIT LBL
75UNAPPROVED
Division of Northeast Imports (DNEI)
8/14/2024
54EFY99HERBALS & BOTANICAL TEAS, N.E.C.
218LIST INGRE
324NO ENGLISH
473LABELING
482NUTRIT LBL
75UNAPPROVED
Division of Northeast Imports (DNEI)
12/22/2021
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
218LIST INGRE
328USUAL NAME
488HEALTH C
Division of Southeast Imports (DSEI)
12/22/2021
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/22/2021
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/22/2021
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/22/2021
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/22/2021
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/22/2021
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/22/2021
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Pablo Francisco Beltran Sanchez's FDA import refusal history?

Pablo Francisco Beltran Sanchez (FEI: 3010048354) has 19 FDA import refusal record(s) in our database, spanning from 12/22/2021 to 5/5/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Pablo Francisco Beltran Sanchez's FEI number is 3010048354.

What types of violations has Pablo Francisco Beltran Sanchez received?

Pablo Francisco Beltran Sanchez has been cited for 9 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Pablo Francisco Beltran Sanchez come from?

All FDA import refusal data for Pablo Francisco Beltran Sanchez is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.